We say goodbye to a historic year, marked by unprecedented difficulties in medical, economical, political and of course, in pure human terms. With hard work and effective oganization, in this difficult time, we could assure that the Bulgarian population had access to reliable and affordable medical prevention and early COVID-19 treatment with hydroxychloroquine. At the same time, by developing, manufacturing and registering it in Bulgaria, we have restored access to thousands of patients suffering from lupus and rheumatoid arthritis to this essential medicine. Tchaikapharma is the only Bulgarian manufacturer of injectable antibiotics, which are vitally important for the hospitals in the country. Obviously, these achievements did not go unnoticed on the Bulgarian stock exchange.

Read the original article here.